Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 885277
                    [Title] => Sponges and humans... alike in many ways
                    [Summary] => 
In November 2010, a new drug for cancer named Halaven (generic name eribulin mesylate) was approved by the US FDA (Food and Drug Administration).

                    [DatePublished] => 2012-12-13 00:00:00
                    [ColumnID] => 135735
                    [Focus] => 0
                    [AuthorID] => 1339989
                    [AuthorName] => Gisela Padilla-Concepcion, PhD
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

RENIERAMYCIN M

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 885277
                    [Title] => Sponges and humans... alike in many ways
                    [Summary] => 
In November 2010, a new drug for cancer named Halaven (generic name eribulin mesylate) was approved by the US FDA (Food and Drug Administration).

                    [DatePublished] => 2012-12-13 00:00:00
                    [ColumnID] => 135735
                    [Focus] => 0
                    [AuthorID] => 1339989
                    [AuthorName] => Gisela Padilla-Concepcion, PhD
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Sponges and humans... alike in many ways

By Gisela Padilla-Concepcion, PhD | December 13, 2012 - 12:00am

In November 2010, a new drug for cancer named Halaven (generic name eribulin mesylate) was approved by the US FDA (Food and Drug Administration).

Science and Environment